Market Tracker

08/26 5:16pm ET

Endo International PLC (NASDAQ:ENDP)

21.03
Delayed Data
As of Aug 26
 0.00 / 0.00%
Today’s Change
12.56
Today|||52-Week Range
84.57
-65.65%
Year-to-Date
Forget Mylan, Buy These 3 Drug Stocks Instead
Aug 26 / Zacks.com - Paid Partner Content
Endo (ENDP) Withdraws Label Expansion Filing for Opana ER
Aug 16 / Zacks.com - Paid Partner Content
Stock Market News for August 26, 2016
Aug 26 / Zacks.com - Paid Partner Content
Why AngloGold Ashanti, Mid-America Apartment Communities, and Endo International Slum...
Aug 15 / MotleyFool.com - Paid Partner Content
Stock Market News for August 25, 2016
Aug 25 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close21.03
Today’s open21.10
Day’s range20.75 - 21.45
Volume4,627,022
Average volume (3 months)9,276,692
Market cap$4.7B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)-55.88%
Earnings growth (this year)-2.15%
Earnings growth (next 5 years)+3.50%
Revenue growth (last year)+13.61%
P/E ratioNM
Price/Sales3.69
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+1.23+1.44%
OPKOPKO Health Inc+0.09+1.00%
GRFSGrifols SA-0.16-0.99%
UTHRUnited Therapeutics ...-1.50-1.22%
Data as of 4:00pm ET, 08/26/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.85
Annual revenue (last year)$3.3B
Annual profit (last year)-$1.5B
Net profit margin-9.18%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Rajiv De Silva
SVP-Operations, Research &
Development Strategy
Robert J. Cobuzzi
Corporate headquarters
Dublin, Dublin

Forecasts